Literature DB >> 15196697

Intrinsic sex differences determine expression of growth hormone-regulated female cytochrome P450s.

Chellappagounder Thangavel1, Martha C Garcia, Bernard H Shapiro.   

Abstract

The masculine profile of cytochrome P450s found in male liver is determined by the episodic secretion of growth hormone characteristic of males. In turn, the female pattern of P450s observed in female rat liver is regulated by the continuous secretion of growth hormone characteristic of the female. In order to determine if intrinsic and possibly permanent sex differences exist in the response of hepatic P450s to growth hormone regulation, we compared the effects of the episodic and continuous growth hormone profiles on the expression of female-dependent isoforms in cultured hepatocytes isolated from both sexes. We observed that female-specific CYP2C12 as well as female-predominant CYP2A1, 3A1, and 2C6 could be induced by growth hormone concentrations equal to as little as 6, 0.6, and 0.06% of the mean circulating hormone profile found in normal females. Irrespective of sex, all four female-dependent isoforms were far more responsive to the continuous growth hormone profile than the episodic pattern. Lastly, female-derived hepatocytes in general responded with strikingly greater induction levels of P450s than male hepatocytes exposed to the same growth hormone profiles. The present findings demonstrate intrinsic, irreversible sex differences in growth hormone-regulated female-dependent P450s.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196697     DOI: 10.1016/j.mce.2004.04.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Bernard H Shapiro
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

2.  Growth hormone: a newly identified developmental organizer.

Authors:  Rajat K Das; Sarmistha Banerjee; Bernard H Shapiro
Journal:  J Endocrinol       Date:  2016-12-15       Impact factor: 4.286

Review 3.  Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes.

Authors:  Hyunyoung Jeong
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-06       Impact factor: 4.481

4.  Gender-specific induction of cytochrome P450s in nonylphenol-treated FVB/NJ mice.

Authors:  Juan P Hernandez; Laura M Chapman; Xiomara C Kretschmer; William S Baldwin
Journal:  Toxicol Appl Pharmacol       Date:  2006-05-25       Impact factor: 4.219

5.  Inherent sex-dependent regulation of human hepatic CYP3A5.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Bernard H Shapiro
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Intrasplenic transplantation of isolated adult rat hepatocytes: sex-reversal and/or suppression of the major constituent isoforms of cytochrome P450.

Authors:  Meena R Sharma; Wojciech Dworakowski; Bernard H Shapiro
Journal:  Toxicol Pathol       Date:  2011-11-14       Impact factor: 1.902

7.  Feminization imprinted by developmental growth hormone.

Authors:  Sarmistha Banerjee; Rajat K Das; Bernard H Shapiro
Journal:  Mol Cell Endocrinol       Date:  2018-08-29       Impact factor: 4.102

8.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

Review 9.  STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Huijuan Yuan; Edmund J Miller
Journal:  JAKSTAT       Date:  2015-09-18

Review 10.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.